WuXi AppTec Co., Ltd.
(OTC: WUXAY)
|
4:51 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $3.76 | Change: +0.18 | %Change: +5.03% | Volume: 1,170 |
Open: | $ 3.68 | Volume: | 1,170 | |
---|---|---|---|---|
High: | $ 3.76 | Yield(%) | 2.90 | |
Low: | $ 3.68 | P/E Ratio (ttm): | 7.26 | |
Dividend ($): | 0.10 | Market Cap ($): | 1.68B | |
EPS ($) | 0.50 | Shares Out: | 380.86M |
% Price Change (last 4 weeks): | 1.47 |
---|---|
% Price Change (last 13 weeks): | -43.97 |
% Price Change (last 26 weeks): | -55.29 |
% Price Change (last 52 weeks): | -49.71 |
% Price Change (year to date): | -56.92 |
Return on Equity (%): | 20.85 |
---|---|
Return on Assets (%): | 15.32 |
Return on Invested Capital (%): | 14.61 |
Gross Profit Margin (%): | 40.59 |
---|---|
Net Profit Margin (%): | 26.50 |
Operating Profit Margin (%): | 27.09 |
|
|
50-day Moving Average: | $4.37 |
---|---|
200-day Moving Average: | $7.75 |
Avg. Daily Vol. (last 50 days): | 6,901 |
Avg. Daily Vol. (last 200 days): | 9,302 |
52-wk high: | $13.02 |
52-wk low: | $3.58 |
Bid: | $n/a |
Ask: | $n/a |
WuXi AppTec Co., Ltd. provides an integrated pharmaceutical platform for the research, development, and production of new drugs. It operates through the following business segments: Contract research organization (CRO) services, Contract manufacturing organization (CMO)/Contract development and manufacturing organization (CDMO) business, and Others. The CRO services segment includes laboratory services in China, laboratory services in the United States, and clinical research services. The company was founded by Ge Li, Ning Zhao, Xiao Zhong Liu, Zhao Hui Zhang, and Tao Lin on December 1, 2000 and is headquartered in Shanghai, China.
|
WuXi AppTec Co., Ltd.
288 Fute Middle Road Waigaoqiao Free Trade Zone Pudong New Area Shanghai SH 200131 Phone: 86.21.2066.3091 Fax: 86.21.5046.3093 http://www.wuxiapptec.com.cn |
Earnings (1year) ($): | n/a |
---|---|
Annual Dividend ($): | 0.10 |
Current P/E Ratio (ttm): | 7.26 |
Book Value ($): | 19.61 |
Cash Flow ($): | 4.70 |
Price/Earnings (x): | 7.26 |
---|---|
Price/Sales (x): | 5.32 |
Price/Book (x): | 0.52 |
Price/Cash Flow (x): | 16.30 |
Quick Ratio (x): | 1.74 |
---|---|
Current Ratio (x): | 2.01 |
LT Debt/Equity (x): | 3.24 |
Total Debt/Equity (x): | 10.44 |